Bliss GVS Pharma Closes Trading Window for Q1 FY27 Results

Bliss GVS Pharma Ltd has announced the closure of its trading window for dealing in the company's securities. This closure is effective from July 1, 2026, and will continue until 48 hours after the announcement of the unaudited financial results for the quarter ended June 30, 2026. The decision is in compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015, and the company's internal code of conduct. Insiders, designated persons, and their immediate relatives are prohibited from trading in the company's shares during this period. The date for the board meeting to approve these financial results will be communicated separately.